INDIANAPOLIS, April 17 /CNW/ -- Eli Lilly and Company (NYSE: LLY) today
announced that Sue Mahony, Ph. D., general manager of Lilly's Canadian
affiliate, will join Lilly's senior management team as the new senior vice
president of human resources beginning May 1. She succeeds Tony Murphy, Ph.
D, who announced his retirement last month.
Mahony joined Lilly more than eight years ago, after more than a decade
in sales and marketing roles in the United Kingdom and Europe for Amgen,
Bristol-Myers Squibb, and Schering-Plough. She was named general manager of
Lilly Canada in 2008 after roles in global marketing and new product
development, including a leadership role in the development of Cymbalta(R).
Mahony was also the Six Sigma leader for Lilly's sales and marketing
"Every facet of our business is directly influenced by the way we hire,
develop, motivate, and engage our employees," said Lilly Chairman, President
and CEO John Lechleiter, Ph. D. "Sue brings a fresh perspective that will help
guide the way we anticipate and respond to a rapidly changing environment. Her
prior experiences, coupled with her record of strong leadership, will enable
Lilly to sustain a strong human resources function and ensure that we are able
to compete and win in the face of unprecedented challenge and opportunity."
Mahony received her bachelor's degree and Ph. D. in pharmacy from Aston
University in Great Britain, and holds an MBA from the London Business School.
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of first-in-class and best-in-class pharmaceutical products by
applying the latest research from its own worldwide laboratories and from
collaborations with eminent scientific organizations. Headquartered in
Indianapolis, Ind., Lilly provides answers - through medicines and information
- for some of the world's most urgent medical needs. Additional information
about Lilly is available at www.lilly.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )
For further information:
For further information: Carole Puls, Eli Lilly, +1-317-277-1421